Structured treatment interruptions: a risky business

Clin Infect Dis. 2005 Feb 15;40(4):601-3. doi: 10.1086/427707. Epub 2005 Jan 26.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Acute Disease
  • Antiretroviral Therapy, Highly Active*
  • CD4 Lymphocyte Count
  • Chronic Disease
  • Drug Administration Schedule
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV-1 / drug effects
  • Humans